Profusa

Biotech

Profusa Expands European Footprint With New Collaborations, Prepares for Investor Spotlight

Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…

Read More »
Featured

5-Minute Deep Dive: Why This Medical Company’s Disruptive Technology Combined With Its Equity Line and Bitcoin Treasury Could Fuel a Major Run

Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…

Read More »
Featured

Big Investors Who Can’t Buy Crypto Are Gobbling Up These Stocks Instead

Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…

Read More »
Healthcare

Profusa Strengthens Leadership as it Advances Wearables and Bitcoin Strategy

Profusa (NASDAQ: PFSA) is ramping up its leadership team just as the company accelerates efforts to commercialize its groundbreaking biosensor…

Read More »
Technical Analysis

Why Profusa (NASDAQ: PFSA) Stock Looks Poised for a Massive Breakout

Profusa (NASDAQ: PFSA) has been making waves in the red-hot wearable technology sector with its innovative Lumee™ Oxygen platform, expansion…

Read More »
Featured

Profusa’s Five Pillars of Growth in the Red-Hot Wearables Market

Profusa (NASDAQ: PFSA) is moving fast to cement its position in the rapidly expanding wearables industry, unveiling a five-pillar growth…

Read More »
Featured

Profusa Expands into Europe and Bitcoin, Joins Wall Street’s Digital Treasury Movement

Profusa (NASDAQ: PFSA), a rising player in digital health, just made two bold moves that caught the attention of investors…

Read More »
Back to top button